Loading
K Pharma,Inc.: what insiders have been doing
Only a handful of insider records exist for K Pharma,Inc., the last one from 13 April 2026, too few to describe a trend. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
JP¥744
Analyst consensus
Income statement
EBITDA-JP¥987.2M
Net income-JP¥993.2M0.0% margin
Valuation
P/Book8.5x
Beta0.43
Balance sheet & cash
Market capJP¥8.6B
Total debtJP¥1.5B
Free Cash Flow-JP¥929.2M
Debt / Equity162%
Profitability & ownership
ROE-67.9%
ROA-24.0%
% insiders66.0%
% institutions10.7%
Last declaration on 13 April 2026
Declarations15 total
44.3% of flowShareXTKSEDINET:S100XYDE
55.7% of flowShareXTKSEDINET:S100VP4M
33.6% of flowShareXTKSEDINET:S100VJ6A
32.1% of flowShareXTKSEDINET:S100TN36
24.7% of flowShareXTKSEDINET:S100SD1R
24.6% of flowShareXTKSEDINET:S100SC6Z
49.7% of flowShareXTKSEDINET:S100S4GB
50.3% of flowShareXTKSEDINET:S100S3Y2
25.2% of flowShareXTKSEDINET:S100S3DQ
25.5% of flowShareXTKSEDINET:S100S2H3
34.3% of flowShareXTKSEDINET:S100S1ML
100.0% of flowShareXTKSEDINET:S100RYTW
100.0% of flowShareXTKSEDINET:S100S1TG
100.0% of flowShareXTKSEDINET:S100S1SN
100.0% of flowShareXTKSEDINET:S100S1N2
15 of 15 declarations
About K Pharma,Inc.
Kei Pharma Co., Ltd. is a Japanese company listed on the XTKS market, specializing in the pharmaceutical sector.